分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Cerebellar microglia-derived IL-17A mitigates autism-related behavioral and synaptic deficits

Yin Jun, Li Wei, Shen Li-Ping, Zhang Wen-Lei, Chen Jun-Yi, Zhang Bei-Bei, Chen Yi-Jie, Li Tong, Li Hong-Zhao, Gao Zhenyu, Xie Shu-Tao, Zhang Qi-Peng, Zhang Chen, Zhang Xiao-Yang, Zhu Jing-Ning

Journal:MOLECULAR PSYCHIATRY

IF:10.4

DOI:10.1038/s41380-026-03454-1

PMID:

Published:2026-02-09

research field:神经科学行为神经科学免疫学分子精神病学

Abstract

Interleukin-17 (IL-17) is a pleiotropic cytokine produced mainly by peripheral T helper 17 cells. Yet, the brain functions of IL-17 derived from central nervous cells remain poorly understood. Here, we find an aberrant IL-17A signaling in the cerebellum of Fmr1- KO mice, a well-established genetic model for autism spectrum disorder (ASD). Cerebellar IL-17A, derived exclusively from microglia, is essential for the regulation of social behaviors by maintaining neuronal excitability and selectively suppressing inhibitory neurotransmission of Purkinje cells (PCs) in the cerebellar Crus I, a brain region critically involved in social cognition. Specific downregulation of IL-17 receptor-mediated signaling in cerebellar PCs recapitulates ASD-like social deficits and repetitive behaviors. Notably, both direct administration of IL-17A and induction of IL-17A release from cerebellar microglia by poly(I:C) effectively restore PC excitability and ameliorate ASD-like symptoms. The findings uncover an indispensable role of microglia-derived IL-17A for cerebellar social processing and suggest potential therapeutic strategies targeting IL-17A signaling for ASD.

本文使用的Yeasen产品

购物车
客服
转染试用